Brian C. Stephenson - Feb 16, 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
Feb 16, 2024
Transactions value $
-$703,976
Form type
4
Date filed
2/21/2024, 04:04 PM
Previous filing
Nov 20, 2023
Next filing
Mar 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +45K +122.17% 81.8K Feb 16, 2024 Direct F1, F2
transaction BBIO Common Stock Tax liability -$704K -18.9K -23.12% $37.21 62.9K Feb 16, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -1.71K -50% $0.00 1.71K Feb 16, 2024 Common Stock 1.71K Direct F1, F4
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -19.99% $0.00 3.11K Feb 16, 2024 Common Stock 778 Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -24.2K -100% $0.00* 0 Feb 16, 2024 Common Stock 24.2K Direct F1, F6
transaction BBIO Restricted Stock Units Options Exercise $0 -946 -12.49% $0.00 6.63K Feb 16, 2024 Common Stock 946 Direct F1, F7
transaction BBIO Restricted Stock Units Options Exercise $0 -17.4K -7.69% $0.00 208K Feb 16, 2024 Common Stock 17.4K Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 121 shares of the Issuer's Common Stock acquired by the Reporting Person on February 15, 2024 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
F3 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs.
F4 The RSUs vested with respect to 1/16th of the underlying shares on August 16, 2020. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F5 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6 The RSUs vested with respect to 1/8th of the underlying shares on May 16, 2022; thereafter, 1/8th of the underlying shares vested on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F7 The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F8 The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.